Pearl Diagnostics, Inc.

New Filing
CIK: 0001922830·Biotechnology·DELAWARE·Filed: Apr 21, 2026
Total Offering

$11,150,000

Amount Sold

$11,150,000

Investors

21

First Sale

Mar 19, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Kieren Marr
Brad Spellberg
John Cammack
Eric Gornstein

Company

Pearl Diagnostics, Inc.

1812 ASHLAND AVENUE

BALTIMORE, MD, 21205

410.614.0300

SEC Filing

0001922830-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free